Seale Anna C, Davies Mark R, Anampiu Kirimi, Morpeth Susan C, Nyongesa Sammy, Mwarumba Salim, Smeesters Pierre R, Efstratiou Androulla, Karugutu Rosylene, Mturi Neema, Williams Thomas N, Scott J Anthony G, Kariuki Samuel, Dougan Gordon, Berkley James A
Emerg Infect Dis. 2016 Feb;22(2):224-32. doi: 10.3201/eid2202.151358.
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the serotypes that cause disease, we analyzed surveillance data for 64,741 hospital admissions in Kilifi, Kenya, during 1998-2011. We evaluated incidence, clinical presentations, and emm types that cause invasive GAS infection. We detected 370 cases; of the 369 for which we had data, most were skin and soft tissue infections (70%), severe pneumonia (23%), and primary bacteremia (14%). Overall case-fatality risk was 12%. Incidence of invasive GAS infection was 0.6 cases/1,000 live births among neonates, 101/100,000 person-years among children <1 year of age, and 35/100,000 among children <5 years of age. Genome sequencing identified 88 emm types. GAS causes serious disease in children in rural Kenya, especially neonates, and the causative organisms have considerable genotypic diversity. Benefit from the most advanced GAS type-specific vaccines may be limited, and efforts must be directed to protect against disease in regions of high incidence.
为确定撒哈拉以南非洲地区A群链球菌(GAS)感染的程度以及引发疾病的血清型,我们分析了1998年至2011年期间肯尼亚基利菲64741例住院病例的监测数据。我们评估了侵袭性GAS感染的发病率、临床表现及emm型。我们共检测到370例病例;在有数据的369例病例中,大多数为皮肤和软组织感染(70%)、重症肺炎(23%)及原发性菌血症(14%)。总体病死率为12%。新生儿侵袭性GAS感染发病率为0.6例/1000活产儿,1岁以下儿童为101/10万/人年,5岁以下儿童为35/10万。基因组测序鉴定出88种emm型。GAS在肯尼亚农村地区的儿童尤其是新生儿中引发严重疾病,且致病生物体具有相当大的基因型多样性。从最先进的GAS型特异性疫苗中获得的益处可能有限,必须致力于在高发病地区预防疾病。